EATG will host a community oriented webinar on intellectual property (IP) barriers to affordable quality medicines and ways in which these can be addressed on 12 July from 12:00 to 13:30 CET.
While the current system of R&D based on intellectual property protection has delivered significant medical advances for patients and societies, over-time, by granting originator companies market exclusivity that delay price competition, it has also led to very high prices for essential medicines.
The webinar will build on the case of pre-exposure prophylaxis for HIV (PrEP) as an example and will reflect on lessons learned to be considered by community activists in advocacy for access to affordable medicines. Participants will be able to ask questions to the presenters following presentations.
Introduction: Patent system and its potential impact on access to medicines for HIV and co-infections (e.g. delaying generic competition)
Part 2: Pre-Exposure Prophylaxis for HIV and Truvada in Europe, Gus Cairns
Part 3: Access to generic PrEP: what to watch out for as community activists, where to find key information and what lessons can we learn from this example, Gaëlle Krikorian
About the speakers
Gaëlle Krikorian is an expert in intellectual property (IP), researcher at IRIS (Institut de recherche interdisciplinaire sur les enjeux sociaux) and with NGOs on the issue of access to medicine.
Gus Cairns is Editor at Aidsmap.com, prevention campaigner and coordinator of the PrEP in Europe Initiative.
How to register: Please register as soon as possible by filling in an online form here: https://www.surveymonkey.de/r/B9W5NY9
Deadline for registration: 11 July 12:00 CET
You will receive a confirmation email with instructions for registration with the webinar online system and access details shortly after the closing date to register.
For further information regarding the webinar or registration, contact Ann Isabelle von Lingen at email@example.com